What is the current market valuation of the Transarterial Chemoembolization Market?

As of 2024, the market valuation was 11.96 USD Billion. Read More

What is the projected market size for the Transarterial Chemoembolization Market by 2035?

The market is expected to reach a valuation of 20.24 USD Billion by 2035. Read More

What is the expected CAGR for the Transarterial Chemoembolization Market during the forecast period?

The market is projected to grow at a CAGR of 4.9% from 2025 to 2035. Read More

Which application segment is anticipated to have the highest valuation in 2035?

The Liver Cancer application segment is projected to reach approximately 5.5 USD Billion by 2035. Read More

What are the key players in the Transarterial Chemoembolization Market?

Key players include Boston Scientific, Bayer, Merit Medical Systems, and Terumo Corporation. Read More

How does the market for Transarterial Chemoembolization compare to Transarterial Radioembolization?

In 2035, Transarterial Chemoembolization is expected to be valued at 8.12 USD Billion, compared to 4.06 USD Billion for Transarterial Radioembolization. Read More

What is the projected valuation for the product type 'Chemotherapeutic Agents' by 2035?

The Chemotherapeutic Agents segment is anticipated to reach approximately 6.5 USD Billion by 2035. Read More

Which end-user segment is expected to grow the most by 2035?

The Hospitals segment is projected to grow to about 6.12 USD Billion by 2035. Read More

What is the expected valuation for the technology segment 'Digital Subtraction Angiography' in 2035?

Digital Subtraction Angiography is expected to reach a valuation of 5.5 USD Billion by 2035. Read More

What is the anticipated growth for the 'Embolic Agents' product type by 2035?

The Embolic Agents segment is projected to grow to approximately 5.0 USD Billion by 2035. Read More

Transarterial Chemoembolization Market

ID: MRFR/HC/7092-HCR

125 Pages

Satyendra Maurya

Last Updated: July 23, 2026

Transarterial Chemoembolization (TACE) Market Research Report Information By Procedure Type (Conventional TACE and DEB-TACE), By Indication (Unresectable HCC and Early-Stage HCC), By Product Type (Chemotherapeutic Agents, Radiotherapeutic Agents, Drug-eluting Particles, and Others), By End User (Hospitals & Clinics, Cancer Research Centers, and Others), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) - Growth & Industry Forecast 2025 To 2035

Transarterial Chemoembolization Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)4.9%

2024 Market Size$ 11.96 Billion

2025 Market Size$ 12.55 Billion

2035 Market Size$ 20.24 Billion

Key Players

Boston Scientific

Bayer

Merit Medical Systems

Terumo Corporation

Cook Medical

Medtronic

Trends

Technological Advancements
Growing Patient Awareness
Regulatory Support

Opportunities

Market Growth Projections
Increasing Geriatric Population
Rising Incidence of Liver Cancer

Summary Table of Contents Segmentation Methodology Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Application (USD Billion) | |
  1. 4.1.1 Liver Cancer | |
  2. 4.1.2 Kidney Cancer | |
  3. 4.1.3 Neuroendocrine Tumors | |
  4. 4.1.4 Hepatocellular Carcinoma | |
  5. 4.1.5 Metastatic Liver Disease |
2. 4.2 Healthcare, BY Procedure Type (USD Billion) | |
  1. 4.2.1 Transarterial Chemoembolization | |
  2. 4.2.2 Transarterial Radioembolization | |
  3. 4.2.3 Selective Internal Radiation Therapy | |
  4. 4.2.4 Chemoembolization with Drug-Eluting Beads | |
  5. 4.2.5 Conventional Chemoembolization |
3. 4.3 Healthcare, BY End User (USD Billion) | |
  1. 4.3.1 Hospitals | |
  2. 4.3.2 Specialty Clinics | |
  3. 4.3.3 Ambulatory Surgical Centers | |
  4. 4.3.4 Cancer Treatment Centers | |
  5. 4.3.5 Research Institutions |
4. 4.4 Healthcare, BY Product Type (USD Billion) | |
  1. 4.4.1 Embolic Agents | |
  2. 4.4.2 Chemotherapeutic Agents | |
  3. 4.4.3 Contrast Agents | |
  4. 4.4.4 Delivery Systems | |
  5. 4.4.5 Catheters |
5. 4.5 Healthcare, BY Technology (USD Billion) | |
  1. 4.5.1 Fluoroscopy | |
  2. 4.5.2 CT Imaging | |
  3. 4.5.3 MRI Guidance | |
  4. 4.5.4 Ultrasound Guidance | |
  5. 4.5.5 Digital Subtraction Angiography |
6. 4.6 Healthcare, BY Region (USD Billion) | |
  1. 4.6.1 North America | | |
    1. 4.6.1.1 US | | |
    2. 4.6.1.2 Canada | |
  2. 4.6.2 Europe | | |
    1. 4.6.2.1 Germany | | |
    2. 4.6.2.2 UK | | |
    3. 4.6.2.3 France | | |
    4. 4.6.2.4 Russia | | |
    5. 4.6.2.5 Italy | | |
    6. 4.6.2.6 Spain | | |
    7. 4.6.2.7 Rest of Europe | |
  3. 4.6.3 APAC | | |
    1. 4.6.3.1 China | | |
    2. 4.6.3.2 India | | |
    3. 4.6.3.3 Japan | | |
    4. 4.6.3.4 South Korea | | |
    5. 4.6.3.5 Malaysia | | |
    6. 4.6.3.6 Thailand | | |
    7. 4.6.3.7 Indonesia | | |
    8. 4.6.3.8 Rest of APAC | |
  4. 4.6.4 South America | | |
    1. 4.6.4.1 Brazil | | |
    2. 4.6.4.2 Mexico | | |
    3. 4.6.4.3 Argentina | | |
    4. 4.6.4.4 Rest of South America | |
  5. 4.6.5 MEA | | |
    1. 4.6.5.1 GCC Countries | | |
    2. 4.6.5.2 South Africa | | |
    3. 4.6.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Boston Scientific (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Bayer (DE) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Merit Medical Systems (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Terumo Corporation (JP) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Cook Medical (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Medtronic (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Halyard Health (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 AngioDynamics (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Stryker Corporation (US) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY APPLICATION |
7. 6.4 US MARKET ANALYSIS BY PROCEDURE TYPE |
8. 6.5 US MARKET ANALYSIS BY END USER |
9. 6.6 US MARKET ANALYSIS BY PRODUCT TYPE |
10. 6.7 US MARKET ANALYSIS BY TECHNOLOGY |
11. 6.8 CANADA MARKET ANALYSIS BY APPLICATION |
12. 6.9 CANADA MARKET ANALYSIS BY PROCEDURE TYPE |
13. 6.10 CANADA MARKET ANALYSIS BY END USER |
14. 6.11 CANADA MARKET ANALYSIS BY PRODUCT TYPE |
15. 6.12 CANADA MARKET ANALYSIS BY TECHNOLOGY |
16. 6.13 EUROPE MARKET ANALYSIS |
17. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION |
18. 6.15 GERMANY MARKET ANALYSIS BY PROCEDURE TYPE |
19. 6.16 GERMANY MARKET ANALYSIS BY END USER |
20. 6.17 GERMANY MARKET ANALYSIS BY PRODUCT TYPE |
21. 6.18 GERMANY MARKET ANALYSIS BY TECHNOLOGY |
22. 6.19 UK MARKET ANALYSIS BY APPLICATION |
23. 6.20 UK MARKET ANALYSIS BY PROCEDURE TYPE |
24. 6.21 UK MARKET ANALYSIS BY END USER |
25. 6.22 UK MARKET ANALYSIS BY PRODUCT TYPE |
26. 6.23 UK MARKET ANALYSIS BY TECHNOLOGY |
27. 6.24 FRANCE MARKET ANALYSIS BY APPLICATION |
28. 6.25 FRANCE MARKET ANALYSIS BY PROCEDURE TYPE |
29. 6.26 FRANCE MARKET ANALYSIS BY END USER |
30. 6.27 FRANCE MARKET ANALYSIS BY PRODUCT TYPE |
31. 6.28 FRANCE MARKET ANALYSIS BY TECHNOLOGY |
32. 6.29 RUSSIA MARKET ANALYSIS BY APPLICATION |
33. 6.30 RUSSIA MARKET ANALYSIS BY PROCEDURE TYPE |
34. 6.31 RUSSIA MARKET ANALYSIS BY END USER |
35. 6.32 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE |
36. 6.33 RUSSIA MARKET ANALYSIS BY TECHNOLOGY |
37. 6.34 ITALY MARKET ANALYSIS BY APPLICATION |
38. 6.35 ITALY MARKET ANALYSIS BY PROCEDURE TYPE |
39. 6.36 ITALY MARKET ANALYSIS BY END USER |
40. 6.37 ITALY MARKET ANALYSIS BY PRODUCT TYPE |
41. 6.38 ITALY MARKET ANALYSIS BY TECHNOLOGY |
42. 6.39 SPAIN MARKET ANALYSIS BY APPLICATION |
43. 6.40 SPAIN MARKET ANALYSIS BY PROCEDURE TYPE |
44. 6.41 SPAIN MARKET ANALYSIS BY END USER |
45. 6.42 SPAIN MARKET ANALYSIS BY PRODUCT TYPE |
46. 6.43 SPAIN MARKET ANALYSIS BY TECHNOLOGY |
47. 6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
48. 6.45 REST OF EUROPE MARKET ANALYSIS BY PROCEDURE TYPE |
49. 6.46 REST OF EUROPE MARKET ANALYSIS BY END USER |
50. 6.47 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE |
51. 6.48 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY |
52. 6.49 APAC MARKET ANALYSIS |
53. 6.50 CHINA MARKET ANALYSIS BY APPLICATION |
54. 6.51 CHINA MARKET ANALYSIS BY PROCEDURE TYPE |
55. 6.52 CHINA MARKET ANALYSIS BY END USER |
56. 6.53 CHINA MARKET ANALYSIS BY PRODUCT TYPE |
57. 6.54 CHINA MARKET ANALYSIS BY TECHNOLOGY |
58. 6.55 INDIA MARKET ANALYSIS BY APPLICATION |
59. 6.56 INDIA MARKET ANALYSIS BY PROCEDURE TYPE |
60. 6.57 INDIA MARKET ANALYSIS BY END USER |
61. 6.58 INDIA MARKET ANALYSIS BY PRODUCT TYPE |
62. 6.59 INDIA MARKET ANALYSIS BY TECHNOLOGY |
63. 6.60 JAPAN MARKET ANALYSIS BY APPLICATION |
64. 6.61 JAPAN MARKET ANALYSIS BY PROCEDURE TYPE |
65. 6.62 JAPAN MARKET ANALYSIS BY END USER |
66. 6.63 JAPAN MARKET ANALYSIS BY PRODUCT TYPE |
67. 6.64 JAPAN MARKET ANALYSIS BY TECHNOLOGY |
68. 6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
69. 6.66 SOUTH KOREA MARKET ANALYSIS BY PROCEDURE TYPE |
70. 6.67 SOUTH KOREA MARKET ANALYSIS BY END USER |
71. 6.68 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE |
72. 6.69 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY |
73. 6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION |
74. 6.71 MALAYSIA MARKET ANALYSIS BY PROCEDURE TYPE |
75. 6.72 MALAYSIA MARKET ANALYSIS BY END USER |
76. 6.73 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE |
77. 6.74 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY |
78. 6.75 THAILAND MARKET ANALYSIS BY APPLICATION |
79. 6.76 THAILAND MARKET ANALYSIS BY PROCEDURE TYPE |
80. 6.77 THAILAND MARKET ANALYSIS BY END USER |
81. 6.78 THAILAND MARKET ANALYSIS BY PRODUCT TYPE |
82. 6.79 THAILAND MARKET ANALYSIS BY TECHNOLOGY |
83. 6.80 INDONESIA MARKET ANALYSIS BY APPLICATION |
84. 6.81 INDONESIA MARKET ANALYSIS BY PROCEDURE TYPE |
85. 6.82 INDONESIA MARKET ANALYSIS BY END USER |
86. 6.83 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE |
87. 6.84 INDONESIA MARKET ANALYSIS BY TECHNOLOGY |
88. 6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION |
89. 6.86 REST OF APAC MARKET ANALYSIS BY PROCEDURE TYPE |
90. 6.87 REST OF APAC MARKET ANALYSIS BY END USER |
91. 6.88 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE |
92. 6.89 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY |
93. 6.90 SOUTH AMERICA MARKET ANALYSIS |
94. 6.91 BRAZIL MARKET ANALYSIS BY APPLICATION |
95. 6.92 BRAZIL MARKET ANALYSIS BY PROCEDURE TYPE |
96. 6.93 BRAZIL MARKET ANALYSIS BY END USER |
97. 6.94 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE |
98. 6.95 BRAZIL MARKET ANALYSIS BY TECHNOLOGY |
99. 6.96 MEXICO MARKET ANALYSIS BY APPLICATION |
100. 6.97 MEXICO MARKET ANALYSIS BY PROCEDURE TYPE |
101. 6.98 MEXICO MARKET ANALYSIS BY END USER |
102. 6.99 MEXICO MARKET ANALYSIS BY PRODUCT TYPE |
103. 6.100 MEXICO MARKET ANALYSIS BY TECHNOLOGY |
104. 6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION |
105. 6.102 ARGENTINA MARKET ANALYSIS BY PROCEDURE TYPE |
106. 6.103 ARGENTINA MARKET ANALYSIS BY END USER |
107. 6.104 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE |
108. 6.105 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY |
109. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
110. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE TYPE |
111. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
112. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE |
113. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY |
114. 6.111 MEA MARKET ANALYSIS |
115. 6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
116. 6.113 GCC COUNTRIES MARKET ANALYSIS BY PROCEDURE TYPE |
117. 6.114 GCC COUNTRIES MARKET ANALYSIS BY END USER |
118. 6.115 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE |
119. 6.116 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY |
120. 6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
121. 6.118 SOUTH AFRICA MARKET ANALYSIS BY PROCEDURE TYPE |
122. 6.119 SOUTH AFRICA MARKET ANALYSIS BY END USER |
123. 6.120 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE |
124. 6.121 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY |
125. 6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION |
126. 6.123 REST OF MEA MARKET ANALYSIS BY PROCEDURE TYPE |
127. 6.124 REST OF MEA MARKET ANALYSIS BY END USER |
128. 6.125 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE |
129. 6.126 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY |
130. 6.127 KEY BUYING CRITERIA OF HEALTHCARE |
131. 6.128 RESEARCH PROCESS OF MRFR |
132. 6.129 DRO ANALYSIS OF HEALTHCARE |
133. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
134. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
135. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE |
136. 6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
137. 6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
138. 6.135 HEALTHCARE, BY PROCEDURE TYPE, 2024 (% SHARE) |
139. 6.136 HEALTHCARE, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion) |
140. 6.137 HEALTHCARE, BY END USER, 2024 (% SHARE) |
141. 6.138 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion) |
142. 6.139 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE) |
143. 6.140 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion) |
144. 6.141 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE) |
145. 6.142 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion) |
146. 6.143 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
147. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
148. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.2.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.2.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.2.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.2.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
149. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.3.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.3.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.3.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.3.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
150. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.4.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.4.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.4.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.4.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
151. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.5.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.5.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.5.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.5.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
152. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.6.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.6.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.6.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.6.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
153. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.7.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.7.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.7.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.7.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
154. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.8.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.8.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.8.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.8.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
155. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.9.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.9.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.9.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.9.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
156. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.10.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.10.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.10.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.10.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
157. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.11.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.11.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.11.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.11.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
158. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.12.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.12.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.12.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.12.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
159. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.13.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.13.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.13.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.13.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
160. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.14.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.14.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.14.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.14.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
161. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.15.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.15.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.15.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.15.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
162. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.16.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.16.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.16.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.16.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
163. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.17.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.17.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.17.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.17.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
164. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.18.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.18.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.18.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.18.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
165. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.19.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.19.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.19.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.19.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
166. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.20.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.20.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.20.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.20.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
167. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.21.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.21.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.21.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.21.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
168. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.22.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.22.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.22.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.22.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
169. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.23.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.23.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.23.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.23.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
170. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.24.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.24.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.24.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.24.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
171. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.25.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.25.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.25.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.25.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
172. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.26.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.26.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.26.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.26.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
173. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.27.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.27.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.27.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.27.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
174. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.28.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.28.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.28.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.28.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
175. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.29.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.29.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.29.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.29.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
176. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.30.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  3. 7.30.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.30.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  5. 7.30.5 BY TECHNOLOGY, 2025-2035 (USD Billion) |
177. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
178. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Transarterial Chemoembolization Market Segmentation

Transarterial Chemoembolization Market By Application (USD Billion, 2025-2035)

Liver Cancer
Kidney Cancer
Neuroendocrine Tumors
Hepatocellular Carcinoma
Metastatic Liver Disease

Transarterial Chemoembolization Market By Procedure Type (USD Billion, 2025-2035)

Transarterial Chemoembolization
Transarterial Radioembolization
Selective Internal Radiation Therapy
Chemoembolization with Drug-Eluting Beads
Conventional Chemoembolization

Transarterial Chemoembolization Market By End User (USD Billion, 2025-2035)

Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Cancer Treatment Centers
Research Institutions

Transarterial Chemoembolization Market By Product Type (USD Billion, 2025-2035)

Embolic Agents
Chemotherapeutic Agents
Contrast Agents
Delivery Systems
Catheters

Transarterial Chemoembolization Market By Transarterial Chemoembolization Market (USD Billion, 2025-2035)

Fluoroscopy
CT Imaging
MRI Guidance
Ultrasound Guidance
Digital Subtraction Angiography

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”